Moderna stock jumps after company posts surprise quarterly profit even as Covid vaccine sales plungeModerna reiterated its full-year 2024 sales guidance of roughly $4 billion.[Collection]

Moderna reiterated its full-year 2024 sales guidance of roughly $4 billion.https://www.cnbc.com/2024/02/22/moderna-mrna-earnings-q4-2023.html